As the face ages, it slowly loses volume and unsightly wrinkles and lines
begin to form. Dr. Lionel Bissoon and Dr. Jeffrey
H. Schorr use some of
the newest injectable fillers to gently give volume to these depressions
leaving an extremely natural result. Restylane® and Radiesse (formerly Radiance
FN) are two soft tissue fillers that are injected under the wrinkle resulting
in a more youthful appearance to the skin.
Restylane is an FDA approved, non-animal based derived hyaluronic acid,
or sugar, found in the skin. It rarely causes any allergic reaction since
it is a naturally occurring substance in humans. The entire procedure
takes 15-30 minutes and most people are able to return to work immediately
afterwards although bruising and swelling can occur. Results for Restylane can last from six months to one year, twice as long as collagen fillers. Restylane can be used to fill the folds or lines around the mouth and
as a lip enhancer.
Radiesse is composed of microscopic calcium particles (calcium hydroxylapatite)—a
substance found in bone and teeth—made into an injectable gel.
It is injected into the face to add volume to wrinkles, most commonly
around the nasio-labial folds, or smile lines. Radiesse’s results
have been reported to last 2-5 years and has little risk of allergic
reaction. It has been FDA approved for multiple applications in the body
and is currently awaiting FDA approval for cosmetic use.
Dr. Schorr treats patients with Botox® or, botulinium toxin, for
those who want a more relaxed look to the face. When Botox is injected
into facial wrinkles, it temporarily paralyzes and smooths them out looking
as if the depressions were actually filled. Botox® is FDA approved
for cosmetic purposes. Its results can be seen in 5-7 days and can last
as long as four months.
To see if you are a candidate for Restylane, Radiesse or Botox, please
schedule a consultation with either Dr.
Bissoon or Dr.
Schorr. We believe
that these fillers can greatly compliment Mesotherapy when used for rejuvenating
the skin (Mesolift).
|